Amgen Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
AMGN Nasdaq 2836 www.amgen.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Amgen Inc.

AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE - May 29th, 2026 2:01 pm
Is Merck & Co. Stock Outperforming the S&P 500? - May 29th, 2026 4:50 am
Possible Bearish Signals With Amgen Insiders Disposing Stock - May 28th, 2026 6:00 am
Novo Nordisk vs. Amgen: Which Pharma Stock Is the Better Buy? - May 27th, 2026 8:32 am
Top Stock Reports for RTX, Wells Fargo & Amgen - May 26th, 2026 2:45 pm
Dow Gives Back Early Gains. Healthcare Stocks Are a Drag. - May 26th, 2026 8:50 am
Honeywell-Backed Quantinuum Seeks $1.05 Billion in US IPO - May 26th, 2026 8:38 am
AMGN Stock Down 13% in 3 Months: Buy the Dip or Book Profits? - May 26th, 2026 7:21 am
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know - May 26th, 2026 7:00 am
Early data for heart drug affirm Lilly’s billion-dollar bet on Verve - May 26th, 2026 5:56 am
3 Blue Chip Dividend Stocks to Buy in June as the Dow Jones Industrial Average Turns 130 - May 26th, 2026 1:20 am
Amgen (AMGN) Announces Retirement of CFO Peter Griffith - May 25th, 2026 1:54 pm
Why Wall Street Thinks This Dividend Stock Could Jump 30% - May 22nd, 2026 11:32 am
CFOs On the Move: Week ending May 22 - May 22nd, 2026 2:49 am
A Look At Amgen (AMGN) Valuation As Tavneos Safety Concerns And Withdrawal Requests Escalate - May 22nd, 2026 12:15 am
Amgen’s ‘boomerang’ CFO reaps $12.5M in cash, retention bonuses - May 21st, 2026 8:35 am
Late-Stage Chronic Kidney Disease Market Analysis Report 2026-2036, Profiles of Key Players - Novartis, Merck & Co, Pfizer, Sanofi, and Johnson & Johnson - May 21st, 2026 7:21 am
Amgen Inc. (AMGN): Navellier’s Long-Term Pick on Pipeline Strength and Sales Growth - May 21st, 2026 2:51 am
3 Large-Cap Stocks Worth Investigating - May 19th, 2026 7:24 pm
AMGEN ANNOUNCES RETIREMENT OF CHIEF FINANCIAL OFFICER PETER GRIFFITH - May 19th, 2026 2:05 pm